PRQR (ProQR Therapeutics N.V. Ordinary Shares) Stock Analysis - Analyst Ratings

ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.51 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate PRQR?

5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.20.

PRQR Key Metrics

Key financial metrics for PRQR
MetricValue
Price$1.51
Market Cap$159.10M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$4.62
52-Week Low$1.07
Volume1.24M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

PRQR Analyst Consensus

5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.20.

Latest PRQR News

Common questions about PRQR

What do analysts rate PRQR?
5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.20.
Does Rallies show PRQR price targets?
Yes. Rallies tracks PRQR analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is PRQR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRQR. It does not provide personalized investment advice.
PRQR

PRQR